Sonnet BioTherapeutics Holdings, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q4 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 2.02M shares, a 326% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 655K shares, a 405% increase from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 130K shares, a 34.3% decline from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 197K shares, a 88.7% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 2.02M +1.55M +326% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-13
Q3 2024 655K +525K +405% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-17
Q2 2024 5.04M +3.7M +277% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 4.62M +3.87M +515% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 475K +160K +51% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-13
Q3 2023 130K -67.7K -34.3% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-17
Q2 2023 1.34M -2.99M -69.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 751K -3.56M -82.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 314K -3.99M -92.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 197K Jul 1, 2022 Sep 30, 2022 10-K 2023-12-14
Q2 2022 4.33M -18.2M -80.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 4.31M -14.4M -77% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 4.31M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q2 2021 22.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 18.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.